Apollo Hospitals To Demerge Pharmacy And Digital Health Businesses

Apollo Hospitals Enterprise Ltd. said it will demerge its pharmacy and digital health platform into a separate entity—Apollo Healthtech Ltd.—which will be listed directly. 

Shareholders of Apollo Hospitals will receive 195.2 shares of Apollo Healthtech for every 100 held. Apollo Healthtech will absorb Apollo Healthco Ltd. and Keimed Pvt. Ltd. as part of the scheme.

 Apollo Healthco’s shareholders will receive 89.5 shares of Apollo Healthtech for every 100 held, while Keimed’s shareholders will receive 3,045.2 shares for every 100 shares. Apollo Hospitals will retain a 15% stake in the demerged company and appoint one director to its board. The new entity posted a turnover of ₹701 million in FY25, representing 0.86% of Apollo’s standalone revenue. 

The listing is targeted within 18–21 months, subject to regulatory approvals including SEBI, NCLT, CCI, and stock exchanges.